Qure.ai is the latest technology partner to join Medtronic's initiative in advancing stroke care management in India.
According to a press statement, their partnership aims to provide AI solutions to comprehensive stroke centres and primary stroke centres. They also seek to establish a hub-and-spoke network that will assist in faster identification, decision-making, and triaging of stroke...
South Korea clears Coreline Soft's AI brain haemorrhage detection software
An AI-powered brain haemorrhage detection software by medtech company Coreline Soft is now listed as a non-insured medical device in South Korea following its approval from the Ministry of Food and Drug Safety.
The software product called AVIEW Neuro CAD automatically detects cerebral haemorrhages in brain CT scans and...
Lunit obtains new CE mark for AI DBT solution
South Korean medical AI company Lunit has received a CE mark under Europe's latest Medical Device Regulation for its AI software for digital breast tomosynthesis (DBT) analysis.
Called Lunit INSIGHT DBT, the software solution analyses 3D images from DBT, enabling fast and accurate diagnosis of breast cancer.
In a press statement, Lunit disclosed its...
See-Mode receives ANZ approvals for its AI breast, thyroid imaging solution
Melbourne-based See-Mode Technologies have recently obtained regulatory approvals in Australia and New Zealand for its AI-powered breast and thyroid ultrasound solution. It is now looking to work with healthcare providers in the region to deploy its software technology.
See-Mode uses AI to detect lesions in ultrasound...
Singaporean startup develops breath test for analysing fat burning
Metanoia Sensing, a deep tech startup in Singapore, has come up with a breath analyser to help people monitor their fat burning and gain insights into their metabolic health risks.
The non-invasive device called MetaNose uses a Micro-Electro-Mechanical System acetone sensor and a proprietary signal processing algorithm to measure...
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's 510(k) clearance for its latest AI-powered analysis software for screening lung nodules.
The company develops AI imaging solutions for diagnosing various chest conditions, aortic disease, spinal disease, and metastatic cancer in the chest.
WHAT IT DOES
Its latest software-as-a-medical device...
Chulalongkorn University researchers develop AI to assess stroke risk
A research team from the Medicine and Engineering faculties of Chulalongkorn University in Thailand has come up with an AI-powered web app to assess patients' risk of stroke caused by heart diseases.
The tool called AICute uses AI to analyse patient's brain scans, together with their symptoms and partial history, and generate a...
South Korean medical AI company Lunit has announced its decision to establish a wholly-owned subsidiary in Europe.
According to a press release, Lunit Europe Holdings will be based in Amsterdam in the Netherlands and will begin local staff recruitment shortly.
WHY IT MATTERS
Although Lunit had a branch office which previously managed its European business, its subsidiary in the continent will...
Vietnamese healthcare AI developer VinBrain has started a new partnership with Stanford University to enhance AI medical imaging.
Based on their latest data use agreement, Stanford will initially provide VinBrain access to about 240,000 anonymised medical images and reports to train and test the AI on its DrAid clinical decision support platform while also helping improve the accuracy of an...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
